A. Martin

发表

Quality-of-Life Assessment in Health Care Research and Practice

M. Stockler, A. Martin, A. Martin, 1998, Evaluation & the health professions.

The Chest Australia Trial: A Randomised Controlled Trial of an Intervention to Reduce Time to Consult with Symptoms of Lung Cancer

J. Emery, P. Murchie, Yvonne Kutzer, 2018 .

Physical activity and fitness in women with metastatic breast cancer

G. Davis, D. Currow, J. Yee, 2013, Journal of Cancer Survivorship.

Physical activity and fitness in women with metastatic breast cancer.

G. Davis, D. Currow, J. Beith, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.

M. Stockler, W. Parulekar, M. Frydenberg, 2023, The Lancet. Oncology.

The LEAD study protocol: a mixed-method cohort study evaluating the lung cancer diagnostic and pre-treatment pathways of patients from Culturally and Linguistically Diverse (CALD) backgrounds compared to patients from Anglo-Australian backgrounds

Jane M. Young, J. Emery, F. Walter, 2018, BMC Cancer.

The LEAD study protocol: a mixed-method cohort study evaluating the lung cancer diagnostic and pre-treatment pathways of patients from Culturally and Linguistically Diverse (CALD) backgrounds compared to patients from Anglo-Australian backgrounds

Jane M. Young, J. Emery, F. Walter, 2018, BMC Cancer.

Do ethnic patients report longer lung cancer intervals than Anglo-Australian patients?: Findings from a prospective, observational cohort study.

Jane M. Young, J. Emery, K. O'Byrne, 2021, European journal of cancer care.

Physical activity for symptom management in women with metastatic breast cancer: a randomised feasibility trial.

G. Davis, D. Currow, J. Yee, 2019, Journal of pain and symptom management.

Physical Activity for Symptom Management in Women With Metastatic Breast Cancer: A Randomized Feasibility Trial on Physical Activity and Breast Metastases

G. Davis, D. Currow, J. Yee, 2019 .

EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma.

M. Stockler, N. Pavlakis, J. Thompson, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)

V. Gebski, N. Pavlakis, Y. Bang, 2023, BMC Cancer.

EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma.

M. Stockler, N. Pavlakis, D. Goldstein, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.